Clinical Trial Update: A Study of ABT-072 in Healthy and Hepatitis C Virus Genotype 1-Infected Adults [Phase 1]

View source ↗

Summary

Abbott conducted a Phase 1 study of ABT-072 in healthy adults and patients with hepatitis C virus genotype 1; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• ABT-072

Snippet

Sponsor: Abbott | Conditions: Hepatitis C | Phase 1 | Status: COMPLETED